Terug
Dagbereik
€ 10,25
€ 10,71
52-Weeksbereik
€ 4,85
€ 14,39
Volume
1.293.346
50D / 200D Gem.
€ 11,16
/
€ 9,67
Vorige Slotkoers
€ 10,76
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -32,0 | 0,4 |
| P/B | 7,5 | 2,9 |
| ROE % | -30,2 | 3,9 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 19,25
+80.9%
Low: € 16,00
High: € 24,00
Forward WPA
-€ 0,45
Omzet Sch.
1,1 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,88
€ 0,88 – € 0,88
|
420 M | 3 |
| FY2029 |
-€ 0,33
-€ 0,33 – -€ 0,33
|
140 M | 3 |
| FY2028 |
-€ 0,58
-€ 1,24 – € 1,12
|
32 M | 9 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -42,10M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-30,23%
ROIC-20,11%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio19,66
Interest Coverage0,00
Waardering
P/E Ratio
-31,95
P/B Ratio7,46
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -42,76M |
| ROE | -30,23% | ROA | -22,10% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -42,10M |
| ROIC | -20,11% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 19,66 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -31,95 | P/B Ratio | 7,46 |
| P/S Ratio | N/A | PEG Ratio | 1,11 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,37B | Enterprise Value | 1,35B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -42,76M | -47,91M | -29,07M | -29,15M | -33,94M |
| EPS (Diluted) | -0,29 | -0,47 | -0,29 | -0,45 | -1,49 |
| Gross Profit | -132.000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -49,33M | -51,52M | -33,92M | -29,91M | -32,48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 193,44M | 110,90M | 89,40M | 123,02M | 38,48M |
| Total Liabilities | 10,20M | 11,26M | 6,86M | 15,56M | 21,40M |
| Shareholders' Equity | 183,24M | 99,64M | 82,55M | 107,46M | 17,08M |
| Total Debt | 753.000,0 | 1,03M | 1,34M | 9,18M | 14,63M |
| Cash & Equivalents | 18,91M | 34,10M | 32,40M | 12,59M | 36,83M |
| Current Assets | 191,66M | 109,43M | 87,55M | 122,62M | 37,96M |
| Current Liabilities | 9,75M | 10,51M | 5,82M | 13,40M | 12,72M |